Candriam S.C.A.
Institutional investor · Portfolio as of Q2 2019
Top Holdings808 positions
Microsoft Corp. | 1.7M | $239M | 3.0% | $110.62 | +13.49% | 2 qtrssince 2019-Q1 | Increased 54 |
Amgen Inc. | 1M | $188.7M | 2.4% | $151.35 | -2.15% | 2 qtrssince 2019-Q1 | Increased 52 |
Vertex Pharmaceuticals Incorporated | 940,506 | $171.7M | 2.1% | $183.78 | -0.22% | 2 qtrssince 2019-Q1 | Increased 70 |
Alphabet Inc. | 139,702 | $152.8M | 1.9% | $57.61 | -6.91% | 2 qtrssince 2019-Q1 | Increased 56 |
Amazon.com, Inc. | 79,031 | $149M | 1.9% | $89.37 | +5.94% | 2 qtrssince 2019-Q1 | Increased 51 |
BIOGEN INC | 624,720 | $145.5M | 1.8% | $236.38 | -1.06% | 2 qtrssince 2019-Q1 | Decreased 0 |
Merck & Co., Inc | 1.7M | $141.1M | 1.8% | $63.09 | +1.38% | 2 qtrssince 2019-Q1 | Increased 51 |
Apple Inc. | 670,382 | $138.2M | 1.7% | $45.22 | +4.60% | 2 qtrssince 2019-Q1 | Decreased 0 |
GILEAD SCIENCES INC | 2M | $134.1M | 1.7% | $49.25 | +4.91% | 2 qtrssince 2019-Q1 | Decreased 0 |
Meta Platforms Inc | 667,996 | $128.4M | 1.6% | $169.08 | +13.07% | 2 qtrssince 2019-Q1 | Increased 56 |
ALIBABA GROUP HLDG LTD | 745,971 | $125.9M | 1.6% | $170.65 | -6.56% | 2 qtrssince 2019-Q1 | Increased 52 |
REGENERON PHARMACEUTICALS | 385,741 | $120.2M | 1.5% | $397.14 | -21.92% | 2 qtrssince 2019-Q1 | Increased 53 |
BRISTOL-MYERS SQUIBB CO | 2.4M | $109.6M | 1.4% | $35.63 | -3.36% | 2 qtrssince 2019-Q1 | Increased 57 |
The Procter & Gamble Co. | 953,891 | $107.6M | 1.3% | $87.20 | +4.57% | 2 qtrssince 2019-Q1 | Increased 60 |
ILLUMINA INC | 249,482 | $91.4M | 1.1% | $306.50 | +16.84% | 2 qtrssince 2019-Q1 | Increased 51 |
Visa Inc | 415,891 | $75.8M | 0.9% | $148.12 | +11.29% | 2 qtrssince 2019-Q1 | Decreased 0 |
ALEXION PHARMACEUTICALS INC | 565,233 | $73.7M | 0.9% | — | — | 2 qtrssince 2019-Q1 | Increased 42 |
DISNEY WALT CO | 491,477 | $73.2M | 0.9% | $106.35 | +25.77% | 2 qtrssince 2019-Q1 | Decreased 0 |
CELGENE CORP | 762,400 | $70.2M | 0.9% | — | — | 2 qtrssince 2019-Q1 | Decreased 0 |
Cisco Systems, Inc. | 1.2M | $68.3M | 0.9% | $43.57 | +1.87% | 2 qtrssince 2019-Q1 | Increased 45 |
Candriam S.C.A. manages $8B across 808 positions as of Q2 2019. Top holdings: MSFT (3.0%), AMGN (2.4%), VRTX (2.1%). Fund DNA: Steady Compounder. HoldingsIntel Score: 2.5/5.0.
Active quarter - 83 new positions, 66 exits, 324 increased. Top move: VRTX (INCREASED, conviction 70). Portfolio: $8.0B across 808 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR